Raynaud's Syndrome Completed Phase 2 Trials for PF-00489791 (DB11736)

Also known as: Raynaud’s phenomenon / Raynaud's Phenomenon / Raynaud’s syndrome / Raynaud Syndrome / Raynaud / Raynaud's Disease / Raynaud phenomenon / Raynauds / Raynaud's syndrome NOS / Raynauds' phen / Raynaud Disease

IndicationStatusPhase
DBCOND0049133 (Raynaud's Syndrome)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01090492PF-00489791 For The Treatment Of Raynaud'sTreatment